InChI=1S/C23H39NO19/c1-6(28)24-11-7(29)2-23(22(37)38,42-18(11)12(31)8(30)3-25)43-19-13(32)9(4-26)40-21(16(19)35)41-17-10(5-27)39-20(36)15(34)14(17)33/h7-21,25-27,29-36H,2-5H2,1H3,(H,24,28)(H,37,38)/t7-,8+,9+,10+,11+,12+,13-,14+,15+,16+,17+,18+,19-,20+,21-,23-/m0/s1 |
CILYIEBUXJIHCO-UITFWXMXSA-N |
CC(=O)N[C@@H]1[C@@H](O)C[C@@](O[C@H]2[C@@H](O)[C@@H](CO)O[C@@H](O[C@@H]3[C@@H](CO)O[C@@H](O)[C@H](O)[C@H]3O)[C@@H]2O)(O[C@H]1[C@H](O)[C@H](O)CO)C(O)=O |
|
Bronsted acid
A molecular entity capable of donating a hydron to an acceptor (Bronsted base).
(via oxoacid )
|
|
epitope
The biological role played by a material entity when bound by a receptor of the adaptive immune system. Specific site on an antigen to which an antibody binds.
mammalian metabolite
Any animal metabolite produced during a metabolic reaction in mammals.
human metabolite
Any mammalian metabolite produced during a metabolic reaction in humans (Homo sapiens).
(via N-acetyl-alpha-neuraminyl-(2->3)-beta-D-galactosyl-(1->4)-D-glucose )
|
|
(6R)-5-(acetylamino)-3,5-dideoxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]-β-L-threo-hex-2-ulopyranonosyl-(2→3)-β-D-galactopyranosyl-(1→4)-β-D-glucopyranose
|
5-acetamido-3,5-dideoxy-D-glycero-α-D-galacto-non-2-ulopyranonosyl-(2→3)-β-D-galactopyranosyl-(1→4)-β-D-glucopyranose
|
(2→3')-a-Sialyllactose
|
HMDB
|
(2→3')-alpha-Sialyllactose
|
HMDB
|
(2S,4S,5R,6R)-2-{[(2R,3S,4S,5R,6S)-3,5-dihydroxy-2-(hydroxymethyl)-6-{[(2R,3R,4R,5R)-1,2,4,5-tetrahydroxy-6-oxohexan-3-yl]oxy}oxan-4-yl]oxy}-5-acetamido-4-hydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxane-2-carboxylic acid
|
HMDB
|
3'-(N-Acetyl-a-neuraminosyl)lactose
|
HMDB
|
3'-(N-Acetyl-alpha-neuraminosyl)lactose
|
HMDB
|
3'-a-Sialyllactose
|
HMDB
|
3'-alpha-Sialyllactose
|
HMDB
|
3'-Monosialyllactose
|
HMDB
|
3'-N-Acetylneuraminyl-D-lactose
|
HMDB
|
3'-N-Acetylneuraminyl-delta-lactose
|
HMDB
|
3'-Sialyl-D-lactose
|
HMDB
|
3'-Sialyl-delta-lactose
|
HMDB
|
3'-sialyllactose
|
HMDB
|
32-N-Acetyl-a-neuraminyllactose
|
HMDB
|
32-N-Acetyl-alpha-neuraminyllactose
|
HMDB
|
a-Neu5Ac-(2→3)-b-D-Gal-(1→4)-D-Glc
|
HMDB
|
A2,3-Sialyllactose
|
HMDB
|
α-N-acetylneuraminyl-(2→3)-β-D-galactosyl-(1→4)-β-D-glucose
|
ChEBI
|
α-Neu5Ac-(2→3)-β-D-Gal-(1→4)-β-D-Glc
|
ChEBI
|
alpha-Neu5Ac-(2→3)-beta-D-Gal-(→4)-D-Glc
|
HMDB
|
alpha-Neu5Ac-(2→3)-beta-delta-Gal-(1→4)-delta-Glc
|
HMDB
|
α-Neup5Ac-(2→3)-β-D-Galp-(1→4)-β-D-Glcp
|
ChEBI
|
GM3 carbohydrate moiety
|
ChEBI
|
N-acetyl-α-neuraminyl-(2→3)-β-D-galactosyl-(1→4)-β-D-glucose
|
UniProt
|
N-Acetylneuraminoyllactose
|
HMDB
|
Neu5Aca2-3Galb1-4Glcb
|
ChEBI
|
Neu5Acα2-3Galβ1-4Glcβ
|
ChEBI
|
O-5-(acetylamino)-3,5-dideoxy-D-glycero-α-D-galacto-2-nonulopyranonosyl-(2→3)-O-β-D-galactopyranosyl-(1→4)-β-D-glucopyranose
|
ChEBI
|
WURCS=2.0/3,3,2/[a2122h-1b_1-5][a2112h-1b_1-5][Aad21122h-2a_2-6_5*NCC/3=O]/1-2-3/a4-b1_b3-c2
|
GlyTouCan
|
4632263
|
Reaxys Registry Number
|
Reaxys
|
4632263
|
Beilstein Registry Number
|
Beilstein
|